Clinical trial
ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan
NCT00158548 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00158548 |
|---|---|
| Title | ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan |
| Official title | Studies on Adding Artesunate to Existing Antimalarial Therapies With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | World Health Organization HealthNet TPO United Nations High Commissioner for Refugees Malaria Control Program, Directorate of Malaria Control, Pakistan |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria, Falciparum Malaria, Vivax Malaria |
| Intervention type | Drug |
| Interventions | SP, chloroquine, amodiaquine, primaquine, artesunate |
| Enrollment | 650 |
| Start date | Jun 1, 2001 |
| Completion | Dec 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | Pakistan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: